Myriad Genetics buy The Goldman Sachs Group, Inc.
Start price
07.05.25
/
50%
€4.00
Target price
07.05.26
€7.05
Performance (%)
36.25%
Price
08.08.25
€5.30
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Myriad Genetics has seen massive gains of 36.25%. This prediction currently runs until 07.05.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | 57.738% | 57.738% |
| iShares Core DAX® | 3.109% | -1.011% |
| iShares Nasdaq 100 | 3.088% | 3.918% |
| iShares Nikkei 225® | 4.760% | 5.119% |
| iShares S&P 500 | 1.840% | 2.235% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $14.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat